These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 32815186)
1. Acceptability of the health-related quality of life instrument EQ-5D-Y-5L among patients in child and adolescent psychiatric inpatient care. Krig S; Åström M; Kulane A; Burström K Acta Paediatr; 2021 Mar; 110(3):899-906. PubMed ID: 32815186 [TBL] [Abstract][Full Text] [Related]
2. EQ-5D-Y-5L as a patient-reported outcome measure in psychiatric inpatient care for children and adolescents - a cross-sectional study. Åström M; Krig S; Ryding S; Cleland N; Rolfson O; Burström K Health Qual Life Outcomes; 2020 Jun; 18(1):164. PubMed ID: 32493419 [TBL] [Abstract][Full Text] [Related]
3. [Development of the German version of EQ-5D-Y-5L to measure health-related quality of life in children and adolescents: Identification of response labels and pilot testing]. Kreimeier S; Greiner W Z Evid Fortbild Qual Gesundhwes; 2019 Aug; 144-145():24-34. PubMed ID: 31378708 [TBL] [Abstract][Full Text] [Related]
4. Patient-caregiver agreement and test-retest reliability of the EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients with haematological malignancies. Zhou W; Shen A; Yang Z; Wang P; Wu B; Herdman M; Luo N Eur J Health Econ; 2021 Sep; 22(7):1103-1113. PubMed ID: 33950465 [TBL] [Abstract][Full Text] [Related]
5. Comparative Psychometric Performance of Common Generic Paediatric Health-Related Quality of Life Instrument Descriptive Systems: Results from the Australian Paediatric Multi-Instrument Comparison Study. Jones R; O'Loughlin R; Xiong X; Bahrampour M; Devlin N; Hiscock H; Chen G; Mulhern B; Dalziel K; Pharmacoeconomics; 2024 Jun; 42(Suppl 1):39-55. PubMed ID: 37955799 [TBL] [Abstract][Full Text] [Related]
6. Testing measurement properties of two EQ-5D youth versions and KIDSCREEN-10 in China. Pei W; Yue S; Zhi-Hao Y; Ruo-Yu Z; Bin W; Nan L Eur J Health Econ; 2021 Sep; 22(7):1083-1093. PubMed ID: 33893889 [TBL] [Abstract][Full Text] [Related]
7. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States. Burström K; Teni FS; Gerdtham UG; Leidl R; Helgesson G; Rolfson O; Henriksson M Pharmacoeconomics; 2020 Aug; 38(8):839-856. PubMed ID: 32307663 [TBL] [Abstract][Full Text] [Related]
8. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare? Feng Y; Devlin N; Herdman M Health Qual Life Outcomes; 2015 Oct; 13():171. PubMed ID: 26489956 [TBL] [Abstract][Full Text] [Related]
9. Measurement properties and responsiveness of the EQ-5D-Y-5L compared to the EQ-5D-Y-3L in children and adolescents receiving acute orthopaedic care. Verstraete J; Marthinus Z; Dix-Peek S; Scott D Health Qual Life Outcomes; 2022 Feb; 20(1):28. PubMed ID: 35177084 [TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms. McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755 [TBL] [Abstract][Full Text] [Related]
11. EQ-5D-Y-3L and EQ-5D-Y-5L proxy report: psychometric performance and agreement with self-report. Fitriana TS; Purba FD; Stolk E; Busschbach JJV Health Qual Life Outcomes; 2022 Jun; 20(1):88. PubMed ID: 35659313 [TBL] [Abstract][Full Text] [Related]
12. Transitioning between the EQ-5D youth and adult descriptive systems in a group of adolescents. Verstraete J; Kind P; Janssen MF; Yang Z; Stolk E; Gebregziabiher A J Patient Rep Outcomes; 2024 Aug; 8(1):93. PubMed ID: 39133433 [TBL] [Abstract][Full Text] [Related]
13. How Well Does the EQ-5D-Y-5L Describe Children With Intellectual Disability?: "There's a Lot More to My Child Than That She Can't Wash or Dress Herself.". Blackmore AM; Mulhern B; Norman R; Reddihough D; Choong CS; Jacoby P; Downs J Value Health; 2024 Feb; 27(2):190-198. PubMed ID: 38043713 [TBL] [Abstract][Full Text] [Related]
14. Psychometric Properties of the EQ-5D-Y-5L for Children With Intellectual Disability. Downs J; Norman R; Mulhern B; Jacoby P; Reddihough D; Choong CS; Finlay-Jones A; Blackmore AM Value Health; 2024 Jun; 27(6):776-783. PubMed ID: 38467188 [TBL] [Abstract][Full Text] [Related]
15. Validity and responsiveness of EQ-5D-Y in children with haematological malignancies and their caregivers. Zhou W; Shen A; Yang Z; Wang P; Wu B; Herdman M; Busschbach J; Luo N Eur J Health Econ; 2024 Nov; 25(8):1361-1370. PubMed ID: 38356007 [TBL] [Abstract][Full Text] [Related]
16. EQ-5D-Y-5L: developing a revised EQ-5D-Y with increased response categories. Kreimeier S; Åström M; Burström K; Egmar AC; Gusi N; Herdman M; Kind P; Perez-Sousa MA; Greiner W Qual Life Res; 2019 Jul; 28(7):1951-1961. PubMed ID: 30739287 [TBL] [Abstract][Full Text] [Related]
17. A Comparison of the Psychometric Properties of the EQ-5D-Y-3L and EQ-5D-Y-5L Using Paediatric Multi-Instrument Comparison (P-MIC) Study Data. Bahrampour M; Devlin N; Jones R; Dalziel K; Mulhern B; Pharmacoeconomics; 2024 Jun; 42(Suppl 1):95-111. PubMed ID: 38748193 [TBL] [Abstract][Full Text] [Related]
18. Cross-cultural adaptation and content validation of the Singapore English version of EQ-5D-Y: a qualitative study. Lee-Yin Tan R; Ng ZM; Chen LA; Herdman M; Luo N Health Qual Life Outcomes; 2024 Sep; 22(1):82. PubMed ID: 39334361 [TBL] [Abstract][Full Text] [Related]
19. Reporting and valuing one's own health: a think aloud study using EQ-5D-5L, EQ VAS and a time trade-off question among patients with a chronic condition. Ernstsson O; Burström K; Heintz E; Mølsted Alvesson H Health Qual Life Outcomes; 2020 Dec; 18(1):388. PubMed ID: 33334348 [TBL] [Abstract][Full Text] [Related]
20. Comparing measurement properties of EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients. Fitriana TS; Purba FD; Rahmatika R; Muhaimin R; Sari NM; Bonsel G; Stolk E; Busschbach JJV Health Qual Life Outcomes; 2021 Nov; 19(1):256. PubMed ID: 34781978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]